Knowledge hub
Articles from the Molekula editorial team
Coverage of chemistry, regulatory updates, methods, supply-chain insight, and product spotlights. New articles published daily.
-
Supplier-news
Strategic sourcing of rare earth catalysts amid geopolitical tensions in 2026
Rare earth catalysts remain essential for fine‑chemical and biopharmaceutical processes, but 2026 geopolitical tensions have tightened supply chains. China still supplies the majority, while export controls and trade disputes increase lead times and price volatility. Diversified sourcing, recycling, and alternative chemistries are the primary risk‑mitigation strategies.
Aug 27, 2026 · 4 min read -
Supplier-news
Buffer and Reducing‑Agent Supply (DTT/TCEP/HEPES/Tris): Sourcing and Quality in 2026
In 2026, DTT and TCEP remain the principal disulphide‑reducing agents, with TCEP offering greater pH stability and longer shelf‑life, while DTT is cheaper but oxidises rapidly. HEPES and Tris buffers are widely available from multiple GMP‑certified manufacturers, with purity specifications of ≥99.5 % and consistent ISO‑9001 compliance. Regulatory frameworks (REACH, USP, EP) continue to dictate documentation and testing requirements.
Aug 24, 2026 · 5 min read -
Supplier-news
Biocatalysis and Enzyme Engineering in Pharma Synthesis: What Is Changing Procurement?
Biocatalysis and enzyme engineering are reshaping pharmaceutical manufacturing, prompting procurement teams to prioritise supplier reliability, regulatory compliance, and sustainability. Procurement now evaluates enzyme activity data, batch‑to‑batch consistency, and life‑cycle impact, while negotiating flexible contracts to accommodate rapid process optimisation.
Aug 23, 2026 · 4 min read -
Supplier-news
Semiconductor‑grade chemical shortages and their knock‑on effects for high‑purity reagents
The semiconductor industry is experiencing a shortage of high‑purity, semiconductor‑grade chemicals due to heightened demand and limited production capacity. This scarcity cascades into biotech and pharmaceutical labs, restricting access to critical reagents and prompting supply‑chain adjustments.
Aug 21, 2026 · 3 min read -
Supplier-news
Cold‑chain and biologics logistics pressures shaping reagent and excipient sourcing in 2026
Cold‑chain constraints and the increasing complexity of biologics logistics are driving changes in how reagents and excipients are sourced in 2026. Suppliers must prioritise temperature‑stable grades, regulatory compliance, and supply‑chain resilience to meet tighter stability windows and global distribution demands.
Aug 18, 2026 · 5 min read -
Supplier-news
GLP‑1 demand and the specialty‑chemical squeeze for peptide synthesis reagents
GLP‑1 analogue sales surpassed $10 bn in 2023, driving a sharp rise in peptide manufacturing. This surge strains the supply of high‑purity reagents such as Fmoc‑protected amino acids and coupling agents, leading to longer lead times and price increases across the specialty‑chemical market.
Aug 7, 2026 · 4 min read -
Supplier-news
China and India API Manufacturing Shifts in 2026 and Their Implications for Western Procurement
By 2026, China is expected to reduce its share of global API output to around 30% from 45% in 2022, while India aims to increase capacity by 20‑25% to meet rising demand. These shifts will pressure Western buyers to diversify supply chains, reassess risk matrices, and adopt stricter quality‑by‑design controls.
Aug 6, 2026 · 5 min read -
Supplier-news
Building a Long-Term Supply Partnership for Biotech R&D
Establishing a reliable, scalable supply partnership is critical for biotech R&D. Key factors include consistent quality (verified via CoA, HPLC, NMR), regulatory compliance (ISO, REACH, TSCA), and transparent communication. Long-term agreements with traceable documentation and flexible scaling support innovation without supply chain disruption.
Jun 29, 2026 · 4 min read -
Supplier-news
Evaluating Supplier Reliability in Fine Chemicals: Lead Time, Documentation, and Traceability
When sourcing fine chemicals and biochemicals, reliability hinges on consistent lead times, comprehensive documentation (including CoA, SDS, and batch-specific data), and full traceability from raw material to final product. Suppliers must meet ISO, REACH, and GHS standards, with batch records and analytical data (e.g., HPLC, NMR) available upon request. Molekula ensures traceability via digital batch records and compliance with USP, EP, and BP specifications.
Jun 28, 2026 · 4 min read -
Supplier-news
A 6-Step Enquiry-to-Delivery Workflow in Practice
A structured 6-step workflow—enquiry, technical validation, quote, order confirmation, dispatch, and delivery tracking—ensures reliable supply of fine chemicals and biochemicals. Each stage includes defined checks, documentation, and compliance verification, with typical lead times of 3–10 business days depending on product availability and regulatory status.
Jun 26, 2026 · 4 min read -
Supplier-news
How Molekula Sources Hard-to-Find Specialty Chemicals
Molekula sources hard-to-find specialty chemicals through direct partnerships with niche manufacturers, rigorous quality control using HPLC, GC-MS, and NMR, and compliance with ISO, REACH, and USP standards. All materials are supplied with full CoA and SDS, ensuring traceability and regulatory alignment.
Jun 25, 2026 · 4 min read -
Supplier-news
Understanding HTS and Tariff Codes for Chemical Imports: A Guide for UK and EU-Based Researchers
Customs Harmonised Tariff Schedule (HTS) codes are essential for classifying chemical imports under UK and EU trade regulations. Accurate HTS codes ensure compliance with REACH, TSCA, and GHS, and prevent delays or penalties. Codes vary by chemical structure, purity, and intended use. Always verify with national customs authorities or a qualified customs broker.
Jun 1, 2026 · 5 min read